| Recruitment status | Enrolling by invitation |
| Unique ID issued by UMIN | UMIN000015803 |
| Receipt No. | R000018387 |
| Scientific Title | Research on musical hallucination with hearing difficulty and cerebrovascular disorder |
| Date of disclosure of the study information | 2014/12/08 |
| Last modified on | 2020/06/25 (Ver. 5) |
| Basic information | ||
| Public title | Research on musical hallucination with hearing difficulty and cerebrovascular disorder | |
| Acronym | Research on musical hallucination with hearing difficulty and cerebrovascular disorder | |
| Scientific Title | Research on musical hallucination with hearing difficulty and cerebrovascular disorder | |
| Scientific Title:Acronym | Research on musical hallucination with hearing difficulty and cerebrovascular disorder | |
| Region |
|
|
| Condition | ||
| Condition | Organic hallucinosis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To identify antiepleptics effects of musical hallucination and the responsible brain region of the symptom. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Identification of responsible brain region of musical hallucination. |
| Key secondary outcomes | 1)The degree of auditory hallucination(Auditory Hallucination Rating Scale)
2) The Relationship between musical hallucination and dominant hemisphere.(Chapman and Chapman handedness test, Edinburgh inventory, f-MRI) |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | To administer antiepileptics | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Musical hallucination
2) Hearing difficulty 3) Cerebrovascular disorder |
|||
| Key exclusion criteria | Severe mental illness and dementia | |||
| Target sample size | 5 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kagoshima University Graduate School of Medical and Dental Sciences | ||||||
| Division name | Department of Psychiatry | ||||||
| Zip code | 890-8520 | ||||||
| Address | 35-1 8-chome, Sakuragaoka, kagoshimashi, kagoshima, 890-8520, Japan | ||||||
| TEL | 099-275-5346 | ||||||
| 02181984@m2.kufm.kagoshima-u.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kagoshima University Graduate School of Medical and Dental Sciences | ||||||
| Division name | Department of Psychiatry | ||||||
| Zip code | 890-8520 | ||||||
| Address | 35-1 8-chome, Sakuragaoka, kagoshimashi, kagoshima, 890-8520, Japan | ||||||
| TEL | 099-275-5346 | ||||||
| Homepage URL | |||||||
| 02181984@m2.kufm.kagoshima-u.ac.jp | |||||||
| Sponsor | |
| Institute | Kagoshima University Graduate School of Medical and Dental Sciences Department of Psychiatry |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board of Kagoshima University Hospital |
| Address | -1 8-chome, Sakuragaoka, kagoshimashi, kagoshima, 890-8520, Japan |
| Tel | 099-275-6692 |
| kufsyomu@kuas.kagoshima-u.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Enrolling by invitation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000018387 |